Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Leptin ELISA Kit (AC3772)
Cat.#: ASET-2361
Specifications
Description Human Leptin ELISA Kit allows for the in vitro quantitative determination of human Leptin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2016 Dehydroepiandrosterone ELISA Kit (AC3427) Quantitative inquiry ASET-1873 Mouse Sprn ELISA Kit (AC3284) Quantitative inquiry ASET-2375 Human CDNF ELISA Kit (AC3786) Quantitative inquiry ASET-2266 Human beta 1 Adrenergic Receptor ELISA Kit (AC3677) Quantitative inquiry ASET-1200 Rat ERK2 ELISA Kit (AC2611) Quantitative inquiry ASET-1837 Mouse Nogo ELISA Kit (AC3248) Quantitative inquiry ASET-2396 Human GCLM ELISA Kit (AC3807) Quantitative inquiry ASET-1209 Chicken TIMP3 ELISA Kit (AC2620) Quantitative inquiry ASET-1159 Mouse Cnrip1 ELISA Kit (AC2570) Quantitative inquiry ASET-1310 Human Fatty Acid Synthase ELISA Kit (AC2721) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket